Protalix BioTherapeutics (PLX) Non-cash Items (2017 - 2025)

Protalix BioTherapeutics has reported Non-cash Items for 9 years, with the latest figure at $3.4 million in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items rose 240.0% year-over-year to $3.4 million; the trailing twelve-month figure through Dec 2025 stood at $3.4 million (up 240.0% YoY), and the FY2025 full-year result was $3.4 million, up 240.0% from the prior year.
• Non-cash Items for Q4 2025 stood at $3.4 million, up from $1.0 million in the prior quarter.
• The five-year high for Non-cash Items was $3.4 million in Q4 2025, with the low at $192500.0 in Q4 2021.
• Average Non-cash Items over 5 years is $1.8 million, with a median of $1.7 million recorded in 2022.
• Year-over-year, Non-cash Items surged 799.45% in 2022 and sank 61.54% in 2024.
• Tracing PLX's Non-cash Items over 5 years: stood at $192500.0 in 2021, then surged by 799.45% to $1.7 million in 2022, then soared by 50.16% to $2.6 million in 2023, then slumped by 61.54% to $1.0 million in 2024, then soared by 240.0% to $3.4 million in 2025.
• The last three Non-cash Items figures came in at $3.4 million (Q4 2025), $1.0 million (Q4 2024), and $2.6 million (Q4 2023), per Business Quant data.

Peer Comparison